+

WO1998016265B1 - Agents embolisants liquides contenant de l'acetate de polyvinyle partiellement hydrolyse - Google Patents

Agents embolisants liquides contenant de l'acetate de polyvinyle partiellement hydrolyse

Info

Publication number
WO1998016265B1
WO1998016265B1 PCT/US1997/018582 US9718582W WO9816265B1 WO 1998016265 B1 WO1998016265 B1 WO 1998016265B1 US 9718582 W US9718582 W US 9718582W WO 9816265 B1 WO9816265 B1 WO 9816265B1
Authority
WO
WIPO (PCT)
Prior art keywords
occludant
new
precursor composition
partially hydrolyzed
radio
Prior art date
Application number
PCT/US1997/018582
Other languages
English (en)
Other versions
WO1998016265A1 (fr
Filing date
Publication date
Priority claimed from US08/734,442 external-priority patent/US5925683A/en
Application filed filed Critical
Priority to EP97912731A priority Critical patent/EP0934086B1/fr
Priority to JP51855298A priority patent/JP3804071B2/ja
Priority to DE69735534T priority patent/DE69735534T2/de
Priority to AU49842/97A priority patent/AU4984297A/en
Publication of WO1998016265A1 publication Critical patent/WO1998016265A1/fr
Publication of WO1998016265B1 publication Critical patent/WO1998016265B1/fr
Priority to US09/291,853 priority patent/US6160025A/en

Links

Abstract

L'invention porte sur une composition de matières comportant des solutions partiellement hydrolysées d'acétate de polyvinyle pouvant servir de précurseur d'un agent embolisant. L'invention porte également sur une procédure d'introduction de solutions dans le corps humain pour former par précipitation des blocs d'occlusion embolisants. Elle porte en outre sur une procédure de traitement des tumeurs hépatiques par embolisation de la veine porte.
PCT/US1997/018582 1996-10-17 1997-10-15 Agents embolisants liquides contenant de l'acetate de polyvinyle partiellement hydrolyse WO1998016265A1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP97912731A EP0934086B1 (fr) 1996-10-17 1997-10-15 Agents embolisants liquides contenant de l'acetate de polyvinyle partiellement hydrolyse
JP51855298A JP3804071B2 (ja) 1996-10-17 1997-10-15 部分的に加水分解されたポリビニルアセテートを含有する液体塞栓剤
DE69735534T DE69735534T2 (de) 1996-10-17 1997-10-15 Flüssige embolisationsmittel aus teilweise hydrolysiertem polyvinylacetat
AU49842/97A AU4984297A (en) 1996-10-17 1997-10-15 Liquid embolic agents containing partially hydrolyzed polyvinyl acetate
US09/291,853 US6160025A (en) 1996-10-17 1999-04-14 Liquid embolic agents

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/734,442 1996-10-17
US08/734,442 US5925683A (en) 1996-10-17 1996-10-17 Liquid embolic agents

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US08/734,442 Continuation-In-Part US5925683A (en) 1996-10-17 1996-10-17 Liquid embolic agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US09/291,853 Continuation US6160025A (en) 1996-10-17 1999-04-14 Liquid embolic agents

Publications (2)

Publication Number Publication Date
WO1998016265A1 WO1998016265A1 (fr) 1998-04-23
WO1998016265B1 true WO1998016265B1 (fr) 1998-06-18

Family

ID=24951721

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/018582 WO1998016265A1 (fr) 1996-10-17 1997-10-15 Agents embolisants liquides contenant de l'acetate de polyvinyle partiellement hydrolyse

Country Status (6)

Country Link
US (2) US5925683A (fr)
EP (1) EP0934086B1 (fr)
JP (1) JP3804071B2 (fr)
AU (1) AU4984297A (fr)
DE (1) DE69735534T2 (fr)
WO (1) WO1998016265A1 (fr)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063070A (en) 1997-08-05 2000-05-16 Target Therapeutics, Inc. Detachable aneurysm neck bridge (II)
EP1003422B1 (fr) 1997-08-05 2006-06-14 Boston Scientific Limited Pont detachable de collet d'anevrisme
US6146373A (en) * 1997-10-17 2000-11-14 Micro Therapeutics, Inc. Catheter system and method for injection of a liquid embolic composition and a solidification agent
US6511468B1 (en) 1997-10-17 2003-01-28 Micro Therapeutics, Inc. Device and method for controlling injection of liquid embolic composition
AU5905599A (en) 1998-09-04 2000-03-27 Boston Scientific Limited Detachable aneurysm neck closure patch
FR2784580B1 (fr) 1998-10-16 2004-06-25 Biosepra Inc Microspheres de polyvinyl-alcool et procedes de fabrication de celles-ci
AU6058000A (en) * 1999-07-12 2001-01-30 Scimed Life Systems, Inc. Liquid based vaso-occlusive compositions
US6346098B1 (en) 2000-03-07 2002-02-12 The Board Of Trustees Of The Leland Stanford Junior University Methods and kits for locally administering an active agent to an interstitial space of a host
DE60130544T2 (de) 2000-03-13 2008-06-26 Biocure, Inc. Embolische zusammensetzungen
US20030212022A1 (en) * 2001-03-23 2003-11-13 Jean-Marie Vogel Compositions and methods for gene therapy
DE01918975T1 (de) * 2000-03-24 2006-04-13 Biosphere Medical, Inc., Rockland Mikrokügelchen zur aktiven Embolisierung
US6729356B1 (en) * 2000-04-27 2004-05-04 Endovascular Technologies, Inc. Endovascular graft for providing a seal with vasculature
US6658288B1 (en) 2000-05-05 2003-12-02 Endovascular Technologies, Inc. Apparatus and method for aiding thrombosis through the application of electric potential
DE10117099A1 (de) * 2000-08-02 2002-02-21 Aesculap Ag & Co Kg Medizintechnisches Produkt, Verfahren zu seiner Herstellung und Bereitstellung für die Chirurgie
US20030180251A1 (en) * 2000-08-02 2003-09-25 Volker Friedrich Medical technical product, method for producing the same and providing the same for surgery
EP1381420A2 (fr) * 2001-04-26 2004-01-21 Christopher H. Porter Procede et appareil d'administration corporelle de matieres
US20030004568A1 (en) * 2001-05-04 2003-01-02 Concentric Medical Coated combination vaso-occlusive device
EP1392182A1 (fr) * 2001-05-04 2004-03-03 Concentric Medical Dispositif vaso-occlusif a base d'hydrogel
AU2002305401A1 (en) * 2001-05-04 2002-11-18 Concentric Medical Hydrogel filament vaso-occlusive device
US6685745B2 (en) 2001-05-15 2004-02-03 Scimed Life Systems, Inc. Delivering an agent to a patient's body
US7687053B2 (en) 2001-08-20 2010-03-30 Boston Scientific Scimed, Inc. Embolic compositions with non-cyanoacrylate rheology modifying agents
US20030050635A1 (en) * 2001-08-22 2003-03-13 Csaba Truckai Embolization systems and techniques for treating tumors
US6911219B2 (en) * 2001-09-27 2005-06-28 Surgica Corporation Partially acetalized polyvinyl alcohol embolization particles, compositions containing those particles and methods of making and using them
WO2003037191A1 (fr) * 2001-10-26 2003-05-08 Concentric Medical Dispositif destine a une occlusion vasculaire
US7341716B2 (en) * 2002-04-12 2008-03-11 Boston Scientific Scimed, Inc. Occlusive composition
CA2503949C (fr) * 2002-10-29 2012-10-23 Toray Industries, Inc. Materiau d'embolisation
HUP0203719A2 (en) * 2002-10-31 2007-09-28 Stepan Dr Gudak Polyuretan composition for fillin blood vessels and method of aplication of it
US20040115164A1 (en) * 2002-12-17 2004-06-17 Pierce Ryan K. Soft filament occlusive device delivery system
WO2004080503A1 (fr) * 2003-03-07 2004-09-23 Micro Therapeutics, Inc. Compositions utilisees pour emboliser des vaisseaux sanguins, presentant de fortes concentrations en agent de contraste
US20050209674A1 (en) * 2003-09-05 2005-09-22 Kutscher Tuvia D Balloon assembly (V)
US20050090804A1 (en) * 2003-10-22 2005-04-28 Trivascular, Inc. Endoluminal prosthesis endoleak management
US20050283182A1 (en) * 2004-06-21 2005-12-22 Concentric Medical, Inc. Systems and methods for intraluminal delivery of occlusive elements
KR20140090270A (ko) 2005-05-09 2014-07-16 바이오스피어 메디칼 에스.에이. 마이크로스피어 및 비이온성 조영제를 사용하는 조성물 및 방법
US8545530B2 (en) * 2005-10-19 2013-10-01 Pulsar Vascular, Inc. Implantable aneurysm closure systems and methods
CA2625826C (fr) * 2005-10-19 2014-08-05 Pulsar Vascular, Inc. Procedes et systemes d'agrafage et de reparation par voie endovasculaire d'anomalies dans des lumieres ou des tissus
WO2007090127A2 (fr) 2006-01-30 2007-08-09 Surgica Corporation Particules d'embolisation intravasculaire compressible, procedes connexes et systemes d'administration
WO2007090130A2 (fr) * 2006-01-30 2007-08-09 Surgica Corporation Particules d'embolisation intravasculaire et procedes associes
US7442105B2 (en) * 2006-05-05 2008-10-28 Freleng Safety Products, Llc Personal visibility marker
US9642693B2 (en) * 2007-04-13 2017-05-09 W. L. Gore & Associates, Inc. Medical apparatus and method of making the same
US20080255678A1 (en) * 2007-04-13 2008-10-16 Cully Edward H Medical apparatus and method of making the same
US9717584B2 (en) * 2007-04-13 2017-08-01 W. L. Gore & Associates, Inc. Medical apparatus and method of making the same
CN103976770B (zh) 2008-09-05 2017-04-12 帕尔萨脉管公司 用于支撑或闭塞生理开口或腔的系统和方法
WO2010062678A2 (fr) * 2008-10-30 2010-06-03 David Liu Échafaudages biocompatibles poreux microsphériques, et procédés et appareil pour la fabrication de ces échafaudages
ES2922979T3 (es) 2009-09-04 2022-09-22 Pulsar Vascular Inc Sistemas para encerrar una abertura anatómica
KR102018035B1 (ko) 2011-06-03 2019-09-05 펄사 배스큘라, 아이엔씨. 추가적인 고정 메커니즘을 가진 동맥류 장치 및 이와 관련된 시스템과 방법
WO2012167150A1 (fr) 2011-06-03 2012-12-06 Pulsar Vascular, Inc. Systèmes et procédés pour fermer une ouverture anatomique, comprenant des dispositifs d'anévrisme absorbant les chocs
US9119625B2 (en) 2011-10-05 2015-09-01 Pulsar Vascular, Inc. Devices, systems and methods for enclosing an anatomical opening
JP6411331B2 (ja) 2012-05-10 2018-10-24 パルサー バスキュラー インコーポレイテッド コイル付き動脈瘤装置
CN102764456B (zh) * 2012-07-24 2014-10-15 上海交通大学 血管栓塞剂及其用途、制备方法
CN111840265B (zh) * 2019-04-29 2023-06-16 李学义 一种乙醇类硬化剂及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2160503A (en) * 1936-02-14 1939-05-30 Chemische Forschungs Gmbh Blood stancher
US2657201A (en) * 1949-11-25 1953-10-27 Du Pont Controlled, heterogeneous hydrolysis of polymeric esters
DE2031724C3 (de) * 1969-06-27 1979-06-28 Nyegaard & Co. A/S., Oslo N-substituierte Trijodbenz- bzw. Jodmethansulfon-am'ide, Verfahren zu deren Herstellung und radiologische Zusammensetzungen
DE2909439A1 (de) * 1979-03-08 1980-09-18 Schering Ag Neue nichtionische roentgenkontrastmittel
US4631188A (en) * 1983-08-31 1986-12-23 S.K.Y. Polymers, Ltd. (Kingston Technologies) Injectable physiologically-acceptable polymeric composition
US4739768B2 (en) * 1986-06-02 1995-10-24 Target Therapeutics Inc Catheter for guide-wire tracking
GB8900376D0 (en) * 1989-01-09 1989-03-08 Nycomed As Iodinated esters
US5202352A (en) * 1990-08-08 1993-04-13 Takeda Chemical Industries, Ltd. Intravascular embolizing agent containing angiogenesis-inhibiting substance
US5690666A (en) * 1992-11-18 1997-11-25 Target Therapeutics, Inc. Ultrasoft embolism coils and process for using them
US5443454A (en) * 1992-12-09 1995-08-22 Terumo Kabushiki Kaisha Catheter for embolectomy
WO1996004954A1 (fr) * 1994-08-17 1996-02-22 Boston Scientific Corporation Implant, et procede et dispositf d'implantation
US5749894A (en) * 1996-01-18 1998-05-12 Target Therapeutics, Inc. Aneurysm closure method
US5702361A (en) * 1996-01-31 1997-12-30 Micro Therapeutics, Inc. Method for embolizing blood vessels

Similar Documents

Publication Publication Date Title
WO1998016265B1 (fr) Agents embolisants liquides contenant de l'acetate de polyvinyle partiellement hydrolyse
DE69826452T2 (de) Stellenspezifische proteinmodifizierung
EP2347770B2 (fr) Procédé de production d' une préparation pharmaceutique injectable
US4317815A (en) LH-RH Antagonists
CA2198917A1 (fr) Liberation prolongee de peptides depuis des compositions pharmaceutiques
CH619614A5 (fr)
CH629475A5 (de) Verfahren zur herstellung von polypeptiden.
ATE49886T1 (de) Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung.
CA2212856A1 (fr) Composes contenant du benzopyranne et techniques d'application
EP0378255A3 (fr) Dérivés de 2-aminopyrimidinone
TW329386B (en) Cough medicine
IE881017L (en) Novel 2ß-morpholino-androstane derivatives and processes for¹their preparation
HUT64518A (en) Process for producing 4-phenyl-piperidine-4-carbixamide derivatives and pharmaceutical preparatives containing these compounds as active agents
CA2085469A1 (fr) Polypeptides hydrosolubles ayant une haute affinite pour les interferons .alpha. et .beta.
CA2381461A1 (fr) Antagonistes de l'hormone de liberation de l'hormone luteinisante (lhrh) ayant des proprietes de dissolution ameliorees
WO1996001634B1 (fr) Compositions a base d'oxytretracycline a action prolongee
DE69001734T2 (de) Aeusserlich anzuwendende amusulosin enthaltende arzneizubereitung.
EP0383346A3 (fr) Catalyseur, procédé pour le préparer et procédé de polymérisation d'oléfines utilisant ce catalyseur
IE51657B1 (en) Lh-rh antagonists
WO1999005103A3 (fr) Derives d'amidino-camptothecine
CA2249753A1 (fr) Procede ameliore de synthese d'alkyl-polyglucosides
ATE30231T1 (de) 3-beta-(3'-(carboxypropionyloxy))-ursa-9(11),12 dien-28-carbonsaeure sowie ihre salze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
US4368138A (en) Water soluble thymidine derivative
US4389414A (en) Prostaglandin compositions
EP0387090A3 (fr) Dérivés de stéroide, leur procédé de préparation et compositions pharmaceutiques les contenant
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载